TRIM65 was originally found to be a genetic polymorphism associated with white matter lesions [10], and subsequent research found that TRIM65 was abnormally highly expressed in many types of cancer, including lung [11], liver [12], bladder [13], and glioma [14]. The gene discussed is TRIM65; the disease is glioma.